[
  {
    "ts": null,
    "headline": "Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now?",
    "summary": "Evotec SE (NASDAQ:EVO) is one of the best debt-free penny stocks to buy right now. On January 8, the company’s Seattle-based subsidiary Just-Evotec Biologics received a new grant from the Gates Foundation. The grant is to be used to enable global access to the company’s biotherapeutics utilizing Evotec Biologics’ molecular design suite. The Gates Foundation […]",
    "url": "https://finnhub.io/api/news?id=5b1b2b9af80fbbff6b7fd5eaaac558ec09bdc5777038887a9bc49da2c2e168cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768757411,
      "headline": "Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now?",
      "id": 138170823,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Evotec SE (NASDAQ:EVO) is one of the best debt-free penny stocks to buy right now. On January 8, the company’s Seattle-based subsidiary Just-Evotec Biologics received a new grant from the Gates Foundation. The grant is to be used to enable global access to the company’s biotherapeutics utilizing Evotec Biologics’ molecular design suite. The Gates Foundation […]",
      "url": "https://finnhub.io/api/news?id=5b1b2b9af80fbbff6b7fd5eaaac558ec09bdc5777038887a9bc49da2c2e168cb"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 80% of the company",
    "summary": "Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...",
    "url": "https://finnhub.io/api/news?id=3e61f8d4c4834a847d59db183d18bd90bc009c849547d3e8525045e64e01eede",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768737626,
      "headline": "Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 80% of the company",
      "id": 138169094,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...",
      "url": "https://finnhub.io/api/news?id=3e61f8d4c4834a847d59db183d18bd90bc009c849547d3e8525045e64e01eede"
    }
  }
]